2007 Media Releases 20 December 2007
Prana Provides Update on Research and Development Program 18 December 2007
Final Patient Dosing in Phase IIa Trial of PBT2 Completed 12 December 2007
Co-Founding Scientist to Present at Credit Suisse Conference 29 November 2007
Prana Receives Positive Report From Independent Data Safety Monitoring Board 1 November 2007
Prana Closes Approximately A$8 Million Placement from Institutional and Professional Investors 29 October 2007
Prana to Present at Rodman & Renshaw 9th Annual Healthcare Conference 24 September 2007
Prana Completes Enrollment in Phase IIa Trial of PBT2 in Alzheimer's Disease Patients 21 September 2007
Professor Rudolph Tanzi, to participate in Alzheimer's Association Expert Panel Discussion 12 September 2007
Prana to Raise A$7.0 million from Institutional and Professional Investors 16 August 2007
Prana today announced that Professor Colin Masters, MD, PhD, a member of Prana's Scientific Advisory Board and a Director of the company from 2000-2007, was awarded the State of Victoria’s most prest 14 August 2007
- Scientists from Emory and Georgia Universities have confirmed the pivotal pathological role of metal ions in Alzheimer's Disease and potentially other major neurodegenerative disorders 6 August 2007
Prana today announced an update on its Phase IIa clinical trial of PBT2 in patients with Alzheimer's disease. 2 July 2007
Prana Biotechnology announces Professor Colin Masters has retired from the Prana Board with effect from July 2nd. 7 June 2007
PBT2 Alters Biomarkers and Rapidly Improves Cognition in two distinct models of Alzheimer's Disease 28 May 2007
Steven Targum, MD, Chief Medical Advisor, will present at the Bank of America 2007 Health Care Conference in Las Vegas 8 May 2007
Prana Biotechnology to Present at the Acumen BioFin/Rodman & Renshaw Fourth Annual Global Healthcare Conference 23 April 2007
Prana has expanded its senior management team to include two US-based pharmaceutical executives. Joining the Prana management team effective immediately are: Axel Unterbeck, PhD, as Chief Strategic 22 March 2007
Renowned Alzheimer Disease Clinicians and Research Scientists to Facilitate Commercialization of Prana Development Program If you are having difficulties opening PDF documents within this site, please click on the link below to download and install Adobe Reader.
|
